Fatty Liver Disease

165

Fatty liver disease refers to a condition in which fat accumulates in the liver, potentially leading to inflammation, liver damage, and fibrosis if left untreated. There are two main types of fatty liver disease:

  • Non-Alcoholic Fatty Liver Disease (NAFLD): Fat accumulation in the liver in the absence of excessive alcohol consumption.
  • Alcoholic Fatty Liver Disease (AFLD): Fat accumulation caused by excessive alcohol intake.

NAFLD is more common and is frequently associated with metabolic issues such as obesity, Type II diabetes, and hypertension.

 

Genes Associated with Fatty Liver Disease

Certain genes have been linked to an increased risk of developing fatty liver disease. Key genes include:

  • PNPLA3 (Patatin-like Phospholipase Domain Containing 3):
    This gene is involved in lipid processing in the liver and is one of the most important genes associated with fatty liver disease, particularly NAFLD. Mutations in this gene (e.g., the I148M allele) are linked to an increased risk of developing fatty liver disease and non-alcoholic steatohepatitis (NASH).
  • TM6SF2 (Transmembrane 6 Superfamily Member 2):
    Involved in liver fat metabolism, variants of this gene are associated with an increased risk of fatty liver disease and liver fibrosis.
  • MBOAT7 (Membrane Bound O-Acyltransferase Domain Containing 7):
    This gene plays a role in lipid processing and storage in the liver, and mutations may enhance the risk for developing NAFLD and NASH.
  • GCKR (Glucokinase Regulator):
    This gene is involved in regulating blood glucose levels and can influence the development of fatty liver disease, especially in individuals with metabolic syndrome or Type II diabetes.

 

How Can Genetic Testing Help?

Genetic testing can reveal whether there is a genetic predisposition to developing fatty liver disease, enabling early diagnosis and intervention. Knowledge of specific genetic variants helps physicians tailor treatment strategies for the prevention or management of fatty liver disease, adjusting therapy to the individual’s needs. This testing can determine the best preventive strategy, such as lifestyle modifications or regular liver monitoring if a genetic predisposition is detected.

 

Why Is Genetic Testing the Best Choice?

Genetic analysis provides reliable information about an individual’s risk of developing fatty liver disease and allows for early preventive measures. Personalized diagnosis through genetic testing enables the selection of targeted prevention and treatment strategies, ensuring an optimized approach to managing liver health.

Related Products

Comprehensive Obesity Management

Genosophy
Privacy Overview
Genosophy

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.